Pandemic (H1N1) 2009 influenza in the UK: Clinical and epidemiological findings from the first few hundred (FF100) cases

Epidemiology and Infection

Volumn 138, Issue 11, 2010, Pages 1531-1541

  McLean, E ^a   Pebody, R G ^a   Campbell, C ^a   Chamberland, M ^a   Hawkins, C ^a   Nguyen Van Tam, J S ^b   Oliver, I ^a   Smith, G E ^a   Ihekweazu, C ^a   Bracebridge, S ^a   Maguire, H ^a   Harris, R ^a   Kafatos, G ^a   White, P J ^a,c   Wynne Evans, E ^a   Green, J ^a   Myers, R ^a   Underwood, A ^a   Dallman, T ^a   Wreghitt, T ^a   Zambon, M ^a   Ellis, J ^a   Phin, N ^a   Smyth, B ^d   McMenamin, J ^e   Watson, J M ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d PUBLIC HEALTH AGENCY   (United Kingdom)

^e HEALTH PROTECTION SCOTLAND   (United Kingdom)

Author keywords

Influenza; pandemic

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL FEATURE; DEATH; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; EPISTAXIS; EUROPE; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; NAUSEA; OTALGIA; PANDEMIC; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; RISK FACTORS; SEX CHARACTERISTICS; TIME FACTORS; YOUNG ADULT;

EID: 77957295717     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001366     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. Morbidity and Mortality Weekly Report 2009;58:400-402.
2. Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. Morbidity and Mortality Weekly Report 2009;58:467-470.
3. Garten RJ, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
4. Health Protection Agency. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Eurosurveillance 2009;14:pii=19232.
5. Health Protection Agency. Epidemiology of new influenza A (H1N1) in the United Kingdom, April-May 2009. Eurosurveillance 2009;14:pii=19213.
6. Health Protection Agency. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave, 24 November 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1258560552857). Accessed 4 December 2009.
7. World Health Organization. Global surveillance during an influenza pandemic (http://www.who.int/csr/disease/swineflu/global-pandemic-influenza- surveilance-apr09pdf). Accessed 15 February 2010.
8. McMenamin J, et al. Minimum dataset for confirmed human cases of influenza H5N1. Lancet 2008;372:2022.
9. Health Protection Agency. The First Few Hundred (FF100) Project. Epidemiological Protocols for Comprehensive Assessment of Early Swine Influenza Cases in the United Kingdom, 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb- C/1257260453727). Accessed 4 December 2009.
10. Gates P, et al. Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system. Vaccine 2009;27:6669-6677.
11. National Centre for Social Research. National Survey of Sexual Attitudes and Lifestyles II, 2000-2001. 2005.
12. Ellis J, Curran M. Simultaneous molecular detection and confirmation of influenza AH5, with internal control. In: Stephenson JR, Warnes A, eds. Diagnostic Virology Protocols. Humana Press (in press).
13. Ellis J, et al. Evaluation of four real-time PCR assays for detection of influenza A (H1N1) v viruses. Eurosurveillance 2009;14:pii=19230.
14. Calatayud L, et al. Pandemic (H1N1) 2009 virus outbreak in a school in London, April-May 2009: an observational study. Epidemiology and Infection 2009;138:183-191.
15. Health Protection Agency West Midlands H1N1v Investigation Team. Preliminary descriptive epidemiology of a large school outbreak of influenza A (H1N1) v in the West Midlands, United Kingdom, May 2009. Eurosurveillance 2009;14:pii=19264.
16. Kar-Purkayastha I, et al. The importance of school and social activities in the transmission of influenza A (H1N1) v: England, April-June 2009. Eurosurveillance 2009;14:pii=19311.
17. Begum F, Pebody RG. Influenza vaccine uptake among the 65 years and over and under 65 years at risk in England, winter season 2008-09. 2009 (http://www.immunisation. nhs.uk/publications/FluVaccineUptake-Winter0809pdf). Accessed 4 December 2009.
18. Ghani AC, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza 2009; RRN1130.
19. Dawood FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 2009;360:2605-2615.
20. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 2009;58:521-524.
21. Miller E, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100-1108.
22. Nicholson KG. Clinical features of influenza. Seminars in Respiratory Infections 1992;7:26-37.
23. Presanis AM, et al. The severity of pandemic H1N1 influenza in the United States, April-July 2009. PLoS Currents: Influenza 2009; RRN1042.
24. National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza. Review of NICE technology appraisal guidance 58, 2009 (http://www.nice.org.uk/nicemedia/pdf/ TA168fullguidancepdf). Accessed 4 December 2009.
25. Aoki FY, Boivin G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. Journal of Clinical Virology 2009;44:255-261.
26. Donaldson LJ, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. British Medical Journal 2009;339:b5213.